![Ari Brettman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ari Brettman
Fondateur chez Anthos Therapeutics, Inc.
Profil
Ari Brettman is the founder of Anthos Therapeutics, Inc. (founded in 2018) and holds the title of Director.
Currently, Dr. Brettman is a Senior Managing Director at Blackstone Life Sciences Advisors LLC (since 2018), a Director at AvenCell Therapeutics, Inc. (since 2021), and a Principal at Clarus Lifesciences III LP (since 2018).
Previously, Dr. Brettman held the position of Director at ESSA Pharma, Inc. (2019-2021), Director at Praxis Precision Medicines, Inc. (2018-2020), and Principal at Clarus Ventures LLC (2014-2018).
Dr. Brettman obtained a doctorate degree from Duke University and an undergraduate degree from Harvard College.
Postes actifs de Ari Brettman
Sociétés | Poste | Début |
---|---|---|
Anthos Therapeutics, Inc.
![]() Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Fondateur | 01/01/2018 |
Clarus Lifesciences III LP
![]() Clarus Lifesciences III LP Investment ManagersFinance Clarus Lifesciences III LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of pharmaceutical, biotechnology and medical devices. It provides financing for seed, early and later stage capital requirements with an investment size of USD 15 - 50 million. | Corporate Officer/Principal | 01/12/2018 |
AvenCell Therapeutics, Inc.
![]() AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 01/08/2021 |
Blackstone Life Sciences Advisors LLC
![]() Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Private Equity Investor | 01/12/2018 |
Anciens postes connus de Ari Brettman
Sociétés | Poste | Fin |
---|---|---|
ESSA PHARMA INC. | Directeur/Membre du Conseil | 26/03/2021 |
PRAXIS PRECISION MEDICINES, INC. | Directeur/Membre du Conseil | 01/10/2020 |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 01/11/2018 |
Formation de Ari Brettman
Duke University | Doctorate Degree |
Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ESSA PHARMA INC. | Health Technology |
PRAXIS PRECISION MEDICINES, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Clarus Lifesciences III LP
![]() Clarus Lifesciences III LP Investment ManagersFinance Clarus Lifesciences III LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of pharmaceutical, biotechnology and medical devices. It provides financing for seed, early and later stage capital requirements with an investment size of USD 15 - 50 million. | Finance |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Blackstone Life Sciences Advisors LLC
![]() Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Finance |
Anthos Therapeutics, Inc.
![]() Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Health Technology |
AvenCell Therapeutics, Inc.
![]() AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |